JP2023515567A5 - - Google Patents

Info

Publication number
JP2023515567A5
JP2023515567A5 JP2022551274A JP2022551274A JP2023515567A5 JP 2023515567 A5 JP2023515567 A5 JP 2023515567A5 JP 2022551274 A JP2022551274 A JP 2022551274A JP 2022551274 A JP2022551274 A JP 2022551274A JP 2023515567 A5 JP2023515567 A5 JP 2023515567A5
Authority
JP
Japan
Prior art keywords
sequence
referred
peptide ligand
ligand according
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022551274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515567A (ja
Filing date
Publication date
Priority claimed from GBGB2002706.6A external-priority patent/GB202002706D0/en
Application filed filed Critical
Publication of JP2023515567A publication Critical patent/JP2023515567A/ja
Publication of JP2023515567A5 publication Critical patent/JP2023515567A5/ja
Ceased legal-status Critical Current

Links

JP2022551274A 2020-02-26 2021-02-26 Pbp3結合二環式ペプチドリガンド Ceased JP2023515567A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2002706.6A GB202002706D0 (en) 2020-02-26 2020-02-26 Pbp3 binding bicyclic peptide ligands
GB2002706.6 2020-02-26
PCT/GB2021/050491 WO2021171029A1 (en) 2020-02-26 2021-02-26 Pbp3 binding bicyclic peptide ligands

Publications (2)

Publication Number Publication Date
JP2023515567A JP2023515567A (ja) 2023-04-13
JP2023515567A5 true JP2023515567A5 (enExample) 2024-03-01

Family

ID=70108251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551274A Ceased JP2023515567A (ja) 2020-02-26 2021-02-26 Pbp3結合二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20230106511A1 (enExample)
EP (1) EP4110791A1 (enExample)
JP (1) JP2023515567A (enExample)
CN (1) CN115443285A (enExample)
GB (1) GB202002706D0 (enExample)
WO (1) WO2021171029A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP2008220317A (ja) * 2007-03-15 2008-09-25 Meiji Seika Kaisha Ltd ペニシリン結合タンパク質(pbp)3トランスペプチダーゼドメイン
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
JP2018521960A (ja) * 2015-04-28 2018-08-09 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) 酵素で活性化された第XII因子(FXIIa)の新規阻害剤
CN106591265B (zh) * 2016-08-18 2019-08-13 武汉职业技术学院 一种青霉素结合蛋白及其应用
GB201706477D0 (en) * 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
WO2019002842A1 (en) * 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands

Similar Documents

Publication Publication Date Title
JP2022546964A5 (enExample)
JP2023514791A5 (enExample)
JP5207734B2 (ja) 細菌感染症を治療するためのダルババンシン組成物
JP2023514791A (ja) 抗感染性二環式ペプチドコンジュゲート
CN101641371B (zh) 肽及其用途
JP2023515567A (ja) Pbp3結合二環式ペプチドリガンド
US20040204378A1 (en) Substituted polyamines as inhibitors of bacterial efflux pumps
ES2979266T3 (es) Procedimientos de tratamiento de infecciones bacterianas con una combinación de vaborbactam y meropenem
JP2013539751A5 (enExample)
ES2682595T3 (es) Nuevo compuesto antiinfeccioso
Conlon et al. Clinical applications of amphibian antimicrobial peptides
CN104302307B (zh) 羊毛硫抗生素mu1140的变体以及具有改善的药理性质和结构特征的其它羊毛硫抗生素
JP7076497B2 (ja) 環状抗微生物性擬ペプチド及びその使用
EP2114989B1 (en) Natural polypeptides for oral health care
ES2909658T3 (es) Lactoferricina y lactoferrampina para el tratamiento de infecciones
JP2019529344A5 (enExample)
US20190315814A1 (en) Lantibiotic variants and uses thereof
WO2022174715A1 (en) Antibacterial and mineralizing compositions and methods of use thereof
JP5803267B2 (ja) S−ニトロソ化α1−酸性糖タンパク質を含有する抗菌剤
CA3066167C (en) Therapeutic uses of fibrinogen gamma prime variants
JP2004526663A (ja) ノビスピリン抗菌ペプチド
RU2825930C1 (ru) Пептид с антибактериальной активностью
US20240041976A1 (en) Composition and use
US9408889B2 (en) Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity
WO2024205444A1 (ru) Пептиды с антибактериальной активностью